[go: up one dir, main page]

MX2013008996A - Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. - Google Patents

Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.

Info

Publication number
MX2013008996A
MX2013008996A MX2013008996A MX2013008996A MX2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A
Authority
MX
Mexico
Prior art keywords
tablet
inflammation
treating pain
novel pharmaceutical
biphasic delivery
Prior art date
Application number
MX2013008996A
Other languages
English (en)
Other versions
MX362435B (es
Inventor
Federico Amezcua Amezcua
Amador Covarrubias Pinedo
Original Assignee
Raam De Sahuayo S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raam De Sahuayo S A De C V Lab filed Critical Raam De Sahuayo S A De C V Lab
Priority to MX2013008996A priority Critical patent/MX362435B/es
Publication of MX2013008996A publication Critical patent/MX2013008996A/es
Priority to PCT/MX2014/000114 priority patent/WO2015016695A1/es
Publication of MX362435B publication Critical patent/MX362435B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas estables que comprenden un sistema tableta-tableta que consiste en la compresión de una tableta dentro de otra tableta con un sistema de entrega bifásica de al menos un análogo del (1R,2R)-rel-2-[(Dimetilamino)metil]-1-(3-metoxifenil) ciclohexanol (Tramadol) y/o sus sales farmacéuticamente aceptables y/o un análogo del 2-[(2,6-Diclorofenii)amino]benceneac etico ácido carboximetilester (Aceclofenaco) y/o sus sales farmacéuticamente estables contenidos en la tableta. Dichas composiciones son útiles para el control y/o prevención y/o tratamiento del dolor agudo y/o crónico así como la inflamación aguda y/o crónica.
MX2013008996A 2013-08-02 2013-08-02 Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. MX362435B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013008996A MX362435B (es) 2013-08-02 2013-08-02 Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.
PCT/MX2014/000114 WO2015016695A1 (es) 2013-08-02 2014-07-24 Novedoso sistema farmacéutico de entrega bifásica para el tratamiento del dolor y la inflamación

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013008996A MX362435B (es) 2013-08-02 2013-08-02 Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.

Publications (2)

Publication Number Publication Date
MX2013008996A true MX2013008996A (es) 2014-03-24
MX362435B MX362435B (es) 2019-01-17

Family

ID=50935221

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008996A MX362435B (es) 2013-08-02 2013-08-02 Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.

Country Status (2)

Country Link
MX (1) MX362435B (es)
WO (1) WO2015016695A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101710792B1 (ko) * 2015-07-14 2017-02-28 주식회사 유영제약 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
CN110141531B (zh) * 2019-06-06 2022-04-19 周大凯 一种包裹活性组分的组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA020867B1 (ru) * 2006-03-06 2015-02-27 Поузен Инк. Лекарственные формы для введения комбинаций лекарственных средств
US8765178B2 (en) * 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
ES2619329T3 (es) * 2007-11-23 2017-06-26 Grünenthal GmbH Composiciones de tapentadol

Also Published As

Publication number Publication date
MX362435B (es) 2019-01-17
WO2015016695A1 (es) 2015-02-05

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
PH12021551189A1 (en) Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
JP2012193216A5 (es)
EA201691454A1 (ru) Композиции придопидина модифицированного высвобождения
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
WO2014205229A8 (en) Use of high dose pridopidine for treating huntington's disease
AR090491A1 (es) Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2012048294A3 (en) Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
EP3300734A3 (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
EA202090637A1 (ru) Способы применения дипивефрина
EP3309555A3 (en) Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
AR093182A1 (es) Metodo para tratar el sobrepeso o la obesidad
IN2015DN01023A (es)
WO2015079010A3 (en) Pharmaceutical composition comprising lacosamide and levetiracetam
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
PH12013500371A1 (en) Therapeutic agent for pain
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
TW201129361A (en) Methods for treating pain
MX362435B (es) Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor

Legal Events

Date Code Title Description
FG Grant or registration